Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

01-12-2020 | Non-Tuberculous Mycobacteria | Research article

Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study

Authors: Nakwon Kwak, Sung A Kim, Sun Mi Choi, Jinwoo Lee, Chang-Hoon Lee, Jae-Joon Yim

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Improvement in health-related quality of life (HRQL) has been suggested as an alternative treatment goal of non-tuberculous mycobacterial pulmonary disease (NTM-PD). This study was performed to elucidate the longitudinal changes in HRQL using St. George’s Respiratory Questionnaire (SGRQ) among patients with NTM-PD according to their clinical course.

Methods

Patients with NTM-PD who participated in Seoul National University Hospital’s prospective NTM cohort were screened. Participants for whom the SGRQ score was estimated with the one-year interval for ≥ three times were included. The longitudinal trends of the SGRQ score were assessed. The impact of the clinical course on the change in the SGRQ score was elucidated using multilevel mixed-effects linear regression with a repeated-measures model.

Results

In total, 114 patients were analyzed. During the median 5-year observation period, 53 patients started anti-mycobacterial treatment and 61 patients were observed without treatment. Among the treated patients, 24 (45.2%) achieved microbiological cure. Patients who required treatment eventually had worsening SGRQ scores with time compared with patients who could be observed without treatment (P < 0.001). In cured patients, the SGRQ score decreased from 33.9 at baseline to 20.8 at 1 year post-treatment (P < 0.001), 21.3 at 2 years (P < 0.001), and 17.6 at 3 years (P < 0.001). The SGRQ scores also decreased for 2 years of treatment in patients with NTM-PD that could not be cured, although this decrease did not last for 3 years of treatment.

Conclusion

Worsening HRQL scores were associated with the initiation of treatment and, in turn, treatment improved HRQL scores of patients with NTM-PD.

Trial registration

This study was registered to the ClinicalTrials.​gov (Identifier: NCT01616745 / registration date: June 12, 2012). The protocol was retrospectively registered.
Literature
1.
go back to reference Lai C-C, Tan C-K, Chou C-H, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16(2):294.CrossRef Lai C-C, Tan C-K, Chou C-H, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16(2):294.CrossRef
3.
go back to reference Henkle E, Hedberg K, Schafer S, Novosad S. Winthrop KLJAotATS. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12(5):642–7.CrossRef Henkle E, Hedberg K, Schafer S, Novosad S. Winthrop KLJAotATS. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12(5):642–7.CrossRef
4.
go back to reference Ringshausen FC, Wagner D, de Roux A, et al. Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009–2014. Emerg Infect Dis. 2016;22(6):1102.CrossRef Ringshausen FC, Wagner D, de Roux A, et al. Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009–2014. Emerg Infect Dis. 2016;22(6):1102.CrossRef
5.
go back to reference Lee H, Myung W, Koh W-J, Moon SM, Jhun BW. Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007–2016. Emerg Infect Dis. 2019;25(3):569.CrossRef Lee H, Myung W, Koh W-J, Moon SM, Jhun BW. Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007–2016. Emerg Infect Dis. 2019;25(3):569.CrossRef
6.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRef Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRef
7.
go back to reference Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–ii64.CrossRef Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–ii64.CrossRef
8.
go back to reference Kwak N, Park J, Kim E, Lee C-H, Han SK, Yim J-J. Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(7):1077–84.CrossRef Kwak N, Park J, Kim E, Lee C-H, Han SK, Yim J-J. Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(7):1077–84.CrossRef
10.
go back to reference Diel R, Ringshausen F, Richter E, Welker L, Schmitz J, Nienhaus A. Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest. 2017;152(1):120–42.CrossRef Diel R, Ringshausen F, Richter E, Welker L, Schmitz J, Nienhaus A. Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest. 2017;152(1):120–42.CrossRef
11.
go back to reference Pasipanodya JG, Ogbonna D, Ferro BE, et al. Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence. Antimicrob Agents Chemother. 2017;61(11):e01206–17.CrossRef Pasipanodya JG, Ogbonna D, Ferro BE, et al. Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence. Antimicrob Agents Chemother. 2017;61(11):e01206–17.CrossRef
12.
go back to reference Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146(2):276–82.CrossRef Wallace RJ Jr, Brown-Elliott BA, McNulty S, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146(2):276–82.CrossRef
13.
go back to reference Czaja CA, Levin AR, Cox CW, Vargas D, Daley CL, Cott GR. Improvement in quality of life after therapy for Mycobacterium abscessus group lung infection. A prospective cohort study. Ann Am Thorac Soc. 2016;13(1):40–8.CrossRef Czaja CA, Levin AR, Cox CW, Vargas D, Daley CL, Cott GR. Improvement in quality of life after therapy for Mycobacterium abscessus group lung infection. A prospective cohort study. Ann Am Thorac Soc. 2016;13(1):40–8.CrossRef
14.
go back to reference Hama M, Ushiki A, Kosaka M, et al. Health-related quality of life in patients with pulmonary non-tuberculous mycobacteria infection. Int J Tuberc Lung Dis. 2016;20(6):747–52.CrossRef Hama M, Ushiki A, Kosaka M, et al. Health-related quality of life in patients with pulmonary non-tuberculous mycobacteria infection. Int J Tuberc Lung Dis. 2016;20(6):747–52.CrossRef
15.
go back to reference Maekawa K, Ito Y, Oga T, et al. High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease. Int J Tuberc Lung Dis. 2013;17(6):829–35.CrossRef Maekawa K, Ito Y, Oga T, et al. High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease. Int J Tuberc Lung Dis. 2013;17(6):829–35.CrossRef
16.
go back to reference Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105(11):1718–25.CrossRef Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med. 2011;105(11):1718–25.CrossRef
17.
go back to reference Kim SJ, Yoon SH, Choi SM, et al. Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease: a prospective cohort study. BMC Pulm Med. 2017;17(1):5.CrossRef Kim SJ, Yoon SH, Choi SM, et al. Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease: a prospective cohort study. BMC Pulm Med. 2017;17(1):5.CrossRef
18.
go back to reference Kwak N, Lee CH, Lee H-J, et al. Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest. Eur Radiol. 2016;26(12):4449–56.CrossRef Kwak N, Lee CH, Lee H-J, et al. Non-tuberculous mycobacterial lung disease: diagnosis based on computed tomography of the chest. Eur Radiol. 2016;26(12):4449–56.CrossRef
19.
go back to reference Clinical & Laboratory Standards Institute. Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing: Approved Guideline, MM18-A. Wayne, PA: CLSI; 2008. Clinical & Laboratory Standards Institute. Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing: Approved Guideline, MM18-A. Wayne, PA: CLSI; 2008.
20.
go back to reference Kim B-J, Lee S-H, Lyu M-A, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol. 1999;37(6):1714–20.CrossRef Kim B-J, Lee S-H, Lyu M-A, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol. 1999;37(6):1714–20.CrossRef
21.
go back to reference Salah IB, Adekambi T, Raoult D, Drancourt M. rpoB sequence-based identification of Mycobacterium avium complex species. Microbiol. 2008;154(12):3715–23.CrossRef Salah IB, Adekambi T, Raoult D, Drancourt M. rpoB sequence-based identification of Mycobacterium avium complex species. Microbiol. 2008;154(12):3715–23.CrossRef
22.
go back to reference Park J, Cho J, Lee C-H, Han SK, Yim J-JJCID. Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis. 2017;64(3):301–8.CrossRef Park J, Cho J, Lee C-H, Han SK, Yim J-JJCID. Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis. 2017;64(3):301–8.CrossRef
23.
go back to reference Kim YS, Byun MK, Jung WY, et al. Validation of the Korean version of the St. George's respiratory questionnaire for patients with chronic respiratory disease. Tuberc Respir Dis. 2006;61(2):121–8.CrossRef Kim YS, Byun MK, Jung WY, et al. Validation of the Korean version of the St. George's respiratory questionnaire for patients with chronic respiratory disease. Tuberc Respir Dis. 2006;61(2):121–8.CrossRef
24.
go back to reference van Ingen J, Aksamit T, Andrejak C, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51:1800170.CrossRef van Ingen J, Aksamit T, Andrejak C, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51:1800170.CrossRef
25.
go back to reference Jones PW, Quirk F, Baveystock C. The St George's respiratory questionnaire. Respir Med. 1991;85:25–31.CrossRef Jones PW, Quirk F, Baveystock C. The St George's respiratory questionnaire. Respir Med. 1991;85:25–31.CrossRef
26.
go back to reference Murray MP, Turnbull K, MacQuarrie S, Hill AT. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J. 2009;33(2):312–8.CrossRef Murray MP, Turnbull K, MacQuarrie S, Hill AT. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J. 2009;33(2):312–8.CrossRef
27.
go back to reference Brusasco V, Hodder R, Miravitlles M, Lee A, Towse L, Kesten S. Health outcomes in a 6-month placebo controlled trial of once-daily tiotropium compared with twice-daily salmeterol in patients with COPD. Thorax. 2003;58:399–404.CrossRef Brusasco V, Hodder R, Miravitlles M, Lee A, Towse L, Kesten S. Health outcomes in a 6-month placebo controlled trial of once-daily tiotropium compared with twice-daily salmeterol in patients with COPD. Thorax. 2003;58:399–404.CrossRef
28.
go back to reference Halpin DM, Peterson S, Larsson TP, Calverley PM. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. Respir Med. 2008;102(11):1615–24.CrossRef Halpin DM, Peterson S, Larsson TP, Calverley PM. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. Respir Med. 2008;102(11):1615–24.CrossRef
29.
go back to reference Furukawa T, Taniguchi H, Ando M, et al. The St. George’s Respiratory Questionnaire as a prognostic factor in IPF. Respir Res. 2017;18(1):18.CrossRef Furukawa T, Taniguchi H, Ando M, et al. The St. George’s Respiratory Questionnaire as a prognostic factor in IPF. Respir Res. 2017;18(1):18.CrossRef
30.
go back to reference Lowes D, Al-Shair K, Newton PJ, et al. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J. 2017;49(2):1601062.CrossRef Lowes D, Al-Shair K, Newton PJ, et al. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J. 2017;49(2):1601062.CrossRef
31.
go back to reference Yeung MW, Khoo E, Brode SK, et al. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: a systematic review. Respirology. 2016;21(6):1015–25.CrossRef Yeung MW, Khoo E, Brode SK, et al. Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: a systematic review. Respirology. 2016;21(6):1015–25.CrossRef
32.
go back to reference Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9–16.CrossRef Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11(1):9–16.CrossRef
33.
go back to reference van Ingen J, Wagner D, Gallagher J, et al. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017;49(2):1601855.CrossRef van Ingen J, Wagner D, Gallagher J, et al. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017;49(2):1601855.CrossRef
34.
go back to reference Jhun BW, Kim S-Y, Moon SM, et al. Development of macrolide resistance and reinfection in refractory Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2018;198(10):1322–30.CrossRef Jhun BW, Kim S-Y, Moon SM, et al. Development of macrolide resistance and reinfection in refractory Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2018;198(10):1322–30.CrossRef
35.
go back to reference Henkle E, Aksamit T, Barker A, et al. Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection. An NTM research consortium workshop report. Ann Am Thorac Soc. 2016;13(9):S379–S84.CrossRef Henkle E, Aksamit T, Barker A, et al. Patient-centered research priorities for pulmonary nontuberculous mycobacteria (NTM) infection. An NTM research consortium workshop report. Ann Am Thorac Soc. 2016;13(9):S379–S84.CrossRef
36.
go back to reference Zweijpfenning S, Kops S, Magis-Escurra C, Boeree MJ, van Ingen J, Hoefsloot W. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort. Respir Med. 2017;131:220–4.CrossRef Zweijpfenning S, Kops S, Magis-Escurra C, Boeree MJ, van Ingen J, Hoefsloot W. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort. Respir Med. 2017;131:220–4.CrossRef
Metadata
Title
Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study
Authors
Nakwon Kwak
Sung A Kim
Sun Mi Choi
Jinwoo Lee
Chang-Hoon Lee
Jae-Joon Yim
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-1165-3

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue